Rochelle Community Hospital purchased and installed Carestream’s Vue Cardio PACS (picture archive and communications system) that provides fully featured viewing and management for its echo cardiograms and nuclear cardiology exams. This versatile system will also support ECGs and other types of cardiac exams that the critical access hospital may add in the future.

The U.S. Food and Drug Administration (FDA) approved Biotronik’s Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices). Biotronik follows this with the launch of its next generation technology platform Ilesto DX.

The U.S. Food and Drug Administration (FDA) approved the Conformable Gore TAG Thoracic Endoprosthesis for endovascular repair of acute and chronic Type B dissections of the descending thoracic aorta. The Conformable Gore TAG Thoracic Endoprosthesis is designed for multiple thoracic etiologies, and is the only device to receive FDA indications for aneurysm, trauma and dissection. Previously, the only approved treatment options were medical management or open surgical repair.

Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Complete SE (self-expanding) vascular stent for use in the lower extremities –– specifically, the superficial femoral artery (SFA) and proximal popliteal artery (PPA), which carry blood through the upper legs.

Clinicians face the challenge of effectively imaging larger patients. Recognizing this trend, Esaote’s new eHD Technology improves every element of the imaging chain and increases ultrasound’s ability to image with more clarity at greater depth.

The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium in late October.

Subscribe Now